Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

IRLAB: Invitation to the Year-End Report 2025 Presentation and Webcast
Healthcare & PharmaceuticalCompany Update

IRLAB: Invitation to the Year-End Report 2025 Presentation and Webcast

February 18, 2026 1:15 AM

IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A)(STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company will hold a presentation in conjunction with the publication of the year-end report for 2025. The interim report will be published on Wednesday, February 25, 2026, at 07:00 CET. The presentation will be held on February 25, 2026, at 10:00 CET via digital webcast....

Read more
Pulse Radiology Education Featured in New Industry Spotlight
Healthcare & PharmaceuticalCompany Update

Pulse Radiology Education Featured in New Industry Spotlight

February 17, 2026 3:00 PM

Pulse Radiology Education, a leading provider of hybrid radiology training programs, has been featured in a new industry spotlight highlighting its founder, Neil Huber, and the company's mission to expand access to advanced ARRT-approved training for working radiologic technologists (RTs). Building on the themes of the interview, Pulse is using this moment to raise awareness about the nationwide shortage of specialized imaging professionals and...

Read more
MEDHOST Announces Strategic Partnership with RevSpring to Enhance Patient Engagement and Financial Experience Solutions 
Healthcare & PharmaceuticalPartnerships

MEDHOST Announces Strategic Partnership with RevSpring to Enhance Patient Engagement and Financial Experience Solutions 

February 17, 2026 12:00 PM

MEDHOST, a leading provider of clinical and financial healthcare technology solutions, today announced a strategic partnership with RevSpring, a leader in healthcare engagement and payment solutions. This collaboration will enable MEDHOST to offer a comprehensive suite of Pre-Care, Post-Care, and IVR solutions designed to elevate the patient experience while enhancing operational efficiency for hospitals and healthcare organizations. Through...

Read more
Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows
Healthcare & PharmaceuticalProduct Announcements

Cercare Medical Releases Version 18 of Neurosuite: Advancing Stroke and Oncology Workflows

February 17, 2026 10:45 AM

Cercare Medical, a leader in advanced neuroimaging software, today announces the launch of CERCARE MEDICAL NEUROSUITE (CMN) Version 18. The new release delivers important innovations for both stroke and oncology workflows, driven directly by clinical feedback and a continued focus on automation, usability, and diagnostic confidence. "Version 18 is about delivering tangible value where it matters most-speed, clarity, and confidence in clinical...

Read more
The Language Group Announces Secure and Compliant On-Demand Healthcare Translation Platform Fetch is Now Patent-Protected
Healthcare & PharmaceuticalProduct Announcements

The Language Group Announces Secure and Compliant On-Demand Healthcare Translation Platform Fetch is Now Patent-Protected

February 17, 2026 9:30 AM

The Language Group (TLG), a leader in language services and technology-enabled solutions, today announced that Fetch, its on-demand healthcare translation platform, is now patent protected. Designed to address language access as a patient safety, compliance, and equity imperative, Fetch brings together people, process, and technology to simplify how clinically critical translations are requested, delivered, and embedded into real-world...

Read more
The Naderi Center Highlights Simple Recovery and Long-Term Results of Earlobe Repair Surgery
Healthcare & PharmaceuticalCompany Update

The Naderi Center Highlights Simple Recovery and Long-Term Results of Earlobe Repair Surgery

February 17, 2026 9:00 AM

WASHINGTON, DC, CHEVY CHASE, MD, and RESTON, VA / ACCESS Newswire / February 17, 2026 / The Naderi Center for Plastic Surgery & Dermatology is educating patients across the DMV on what to expect during recovery after earlobe repair surgery, a popular in-office procedure designed to correct torn, stretched, or elongated earlobes caused by heavy earrings, trauma, or aging. Performed In-Office with Local Anesthesia and Dissolvable Sutures...

Read more
CVS Health Makes Health Insurance Simpler and More Affordable for Americans
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Health Makes Health Insurance Simpler and More Affordable for Americans

February 17, 2026 9:00 AM

Originally published on CVS Health Company News CVS Health® recently announced key milestones in its ongoing effort to make health care simpler and more affordable for American consumers. "Our ambition is to be America's most trusted health care company," said David Joyner, President and CEO of CVS Health. "We are partnering with the Administration and Congress to deliver common-sense solutions that make health care more affordable and improve...

Read more
Alpha Genesis Successfully Completes USDA Triennial Re-Licensing Inspection as Company Accelerates National Expansion
Healthcare & PharmaceuticalCompany Update

Alpha Genesis Successfully Completes USDA Triennial Re-Licensing Inspection as Company Accelerates National Expansion

February 17, 2026 9:00 AM

Alpha Genesis, Inc., America's largest primate research center, proudly announces the successful completion of its triennial re-licensing inspection by the United States Department of Agriculture under the Animal Welfare Act. The inspection, conducted by the USDA Animal and Plant Health Inspection Service, comes at a critical moment for AGI as the company expands capacity, increases breeding output, and scales research operations to meet rising...

Read more
Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))
Healthcare & PharmaceuticalRegulatory

Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))

February 17, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the filing of a provisional patent application with the U.S. Patent and Trademark Office (USPTO) for its proprietary sublingual powder formulation of Meclizine. The application, titled "A Sublingual Powder Formulation of Meclizine and Methods of Use Thereof,"...

Read more
African Leaders Call for Sustainable Malaria Financing as Progress Stalls and Funding Crisis Deepens
Healthcare & PharmaceuticalFinancing

African Leaders Call for Sustainable Malaria Financing as Progress Stalls and Funding Crisis Deepens

February 17, 2026 8:25 AM

Against a backdrop of stalled progress, declining international funding, and intensifying threats, African Heads of State and Government today issued a unified call for a new era of malaria financing at the 39th African Union Summit in Ethiopia. The African Union Malaria Progress Report 2025, presented by President Advocate Duma Gideon Boko of the Republic of Botswana and Chair of the African Leaders Malaria Alliance (ALMA) (www.ALMA2030.org),...

Read more
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation
Healthcare & PharmaceuticalCompany Update

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation

February 17, 2026 8:25 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced the Company's recently appointed President and Chief Executive officer, Rami Levin, in close alignment with the Board of Directors, has recruited key members to his new executive team. These new appointments,...

Read more
Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models
Healthcare & PharmaceuticalCompany Update

Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models

February 17, 2026 8:00 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a preclinical-stage biotechnology company developing small-molecule therapeutics targeting fundamental epigenetic and metabolic drivers of cancer, today announced new in vitro data demonstrating that Telomir-1 (Telomir-Zn) induces broad tumor cell mortality across biologically distinct subtypes of triple-negative breast cancer (TNBC). Iron-rescue experiments confirmed that...

Read more
Black Book's 2026 State of Behavioral Health IT Report Ranks Netsmart #1
Healthcare & PharmaceuticalAwards

Black Book's 2026 State of Behavioral Health IT Report Ranks Netsmart #1

February 17, 2026 7:45 AM

Black Book Market Research released its 2026 State of Behavioral Health IT report, a comprehensive market benchmark spanning over twenty behavioral health IT categories and scored using Black Book's 18‑KPI performance framework. The report's 2026 Behavioral Health IT User Survey (n=1,104) captures the lived experience of frontline clinicians, prescribers, revenue cycle leaders, IT analysts, and executive decision-makers across outpatient,...

Read more
Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE
Healthcare & PharmaceuticalCompany Update

Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE

February 17, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mNEXSPIKE® (mRNA-1283), a new COVID vaccine, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 12 years and older. This marketing authorization follows the positive opinion adopted by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) and marks Moderna's...

Read more
AGFA HealthCare Brings KLAS-Awarded Enterprise Imaging That Reduces Complexity to HIMSS 2026
Healthcare & PharmaceuticalCompany Update

AGFA HealthCare Brings KLAS-Awarded Enterprise Imaging That Reduces Complexity to HIMSS 2026

February 17, 2026 3:45 AM

At HIMSS 2026, AGFA HealthCare will showcase its latest Enterprise Imaging innovations designed to simplify IT operations, strengthen interoperability, and deliver a faster, more intuitive imaging experience for clinicians. Building on three consecutive years of Best in KLAS® recognitions, attendees can visit Booth #2225 to explore how AGFA HealthCare is helping organizations bring clarity back to imaging complexity. As healthcare systems...

Read more
BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis
Healthcare & PharmaceuticalCompany Update

BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis

February 17, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that the European Patent Office (EPO) has issued a Decision to Grant European Patent No. 4539857 covering the Company's proprietary sublingual cladribine oral thin film (ODF) drug delivery technology. The grant will take effect upon publication of the mention of grant in...

Read more
Vanna Health Appoints Liz Kwo, MD, MBA, MPH as President to Lead Next Phase of National Growth
Healthcare & PharmaceuticalCompany Update

Vanna Health Appoints Liz Kwo, MD, MBA, MPH as President to Lead Next Phase of National Growth

February 16, 2026 4:15 PM

Vanna Health, a leader in value-based care for people with serious mental illness (SMI), today announced that Dr. Liz Kwo has joined the company as President. In this role, Dr. Kwo will partner closely with Founder and CEO Dr. Giovanni Colella to guide Vanna Health through its next phase of growth, including multi-state expansion, deeper payer partnerships, and continued scaling of its community-based care model and technology platform. Vanna...

Read more
Why Keloids Keep Growing According to Dr. Mendez and Dr. Salloum
Healthcare & PharmaceuticalCompany Update

Why Keloids Keep Growing According to Dr. Mendez and Dr. Salloum

February 16, 2026 9:00 AM

Keloid scars affect millions of people worldwide, yet many patients remain confused about why these scars continue to grow long after a wound has healed. According to specialists at The Keloid Plastic Surgery Center in Miami, keloids are not simply cosmetic scars-they are the result of an overactive healing response that can progress unpredictably without appropriate treatment. Led by Dr. Roberto Mendez and Dr. Gabriel Salloum, the center...

Read more
Save a Life by NHCPS Transitions to Advanced Medical Certification to Unify Accredited Online Training
Healthcare & PharmaceuticalCompany Update

Save a Life by NHCPS Transitions to Advanced Medical Certification to Unify Accredited Online Training

February 16, 2026 8:00 AM

Save a Life by NHCPS, a global initiative dedicated to empowering individuals through free life support education, is officially merging with its parent company Advanced Medical Certification (AMC) to unify its accredited training programs under one trusted platform. The transition marks the next phase in Save a Life's mission to make high-quality, accessible medical education available to everyone - while offering a more streamlined and...

Read more
Leafbuyer Technologies Reports Second Quarter Fiscal 2026 Results
Healthcare & PharmaceuticalCompany Update

Leafbuyer Technologies Reports Second Quarter Fiscal 2026 Results

February 16, 2026 8:00 AM

Leafbuyer Technologies, Inc. (OTC:LBUY), a leading cannabis marketing technology platform, today announced financial results for the quarter ended December 31, 2025, as reported in its Form 10-Q filed with the Securities and Exchange Commission. For the three months ended December 31, 2025, revenue totaled approximately $962,802, compared to $1,717,127 in the same period last year, reflecting a 43% year-over-year decrease. Gross profit for the...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?